Table 2.
Summary glycans | COVID-19 patients (n = 104) | Controls (n = 104) | Z | P |
---|---|---|---|---|
Fucosylation | 82.54 (72.36–87.21) | 95.64 (94.12–96.69) | 10.874 | <0.001 |
Bisecting GlcNAc | 14.30 (12.57–15.66) | 15.39 (13.48–17.08) | 2.398 | 0.016 |
Galactosylation | 76.13 (67.14–83.02) | 69.21 (63.41–72.93) | 4.668 | <0.001 |
Sialylation | 29.68 (21.75–39.29) | 20.60 (17.48–23.82) | 6.296 | <0.001 |
GlcNAc, N-acetylglucosamine.